Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study

✍ Scribed by Holowiecki, J; Grosicki, S; Robak, T; Kyrcz-Krzemien, S; Giebel, S; Hellmann, A; Skotnicki, A; Jedrzejczak, W W; Konopka, L; Kuliczkowski, K

• Book ID: 110055862
• Publisher: Nature Publishing Group
• Year: 2004
• Tongue: English
• Weight: 150 KB
• Volume: 18
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/sj.leu.2403336